SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RT who wrote (18044)1/22/1999 1:49:00 PM
From: VLAD  Read Replies (3) of 23519
 
RT,

I'll try to be an optimist for a change:

Here is what we can look forward to in 1999 beginning with next Thursday's cc:

1)A profitable Q4 1999 (at least 3 cents a share).
2)A positive forward looking statement including reassurances that a partner will soon be signed within a "reasonable" time span.
3)Proof to the analysts that Vivus' restructuring moves now allows it to operate in the black.
4)Information on progressing R&D including Alibra, gene therapy, incontinence and premature ejaculation.
5)Information explaining how Vivus is informing the PCP in the interim while they don't have a domestic partner.

Later in Q1:

1)Positive information regarding Astra/Zenica's MUSE launchings in the EU countries.
2)News relating to milestone payments as MUSE gets individual approvals in Spain, Italy, Germany, and France.
3)More bad surrounding Viagra safety issues. a domestic class action is IMO long overdue.

In the course of 1999:

1)Profitable quarters throughout with a FY 1999 earnings exceeding current expectations by at least 100% and probably by 200%
2)More developments on the R&D front.
3)Domestic scipts rebound back to preViagra levels.

It will all happen. Give it at least another month or two.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext